PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19303929-0	2009	Improved bioavailability of darunavir by use of kappa-carrageenan versus microcrystalline cellulose as pelletisation aid.	Darunavir	28-37	activation induced cytidine deaminase	Canis lupus familiaris	117-120	
19303929-1	2009	The aim of this study was to produce pellet formulations containing a high drug load (80%) of the poorly soluble HIV-protease inhibitor darunavir, using wet extrusion/spheronization with kappa-carrageenan or microcrystalline cellulose (MCC) as pelletization aid.	Darunavir	136-145	activation induced cytidine deaminase	Canis lupus familiaris	258-261